By Keith L. Carson
Volume 12, Issue 3 (Fall 2013)
Call me jaded. One of the latest fads in the production of biologics is “continuous processing.” So let’s concede that the upstream realm can lend itself to continuous processing, but the really hard stuff was always on the downstream side. Here we’ve had to deal with product clarification and purification, which typically involve crossflow (tangential) filtration and chromatography run in a batch mode, with regeneration steps in between whatever was considered a batch…
Citation: Carson KL. From the Editor-in-Chief: Stem-to-Stern, Continuous Process for Biologics? BioProcess J, 2013; 12(3): 4. https://doi.org/10.12665/J123.Carson
Posted online July 27, 2026